Literature DB >> 5281014

Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine.

S Hanessian, W Regan, D Watson, T H Haskell.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 5281014     DOI: 10.1038/newbio229209a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN: 0090-0028


× No keyword cloud information.
  32 in total

1.  Cross-reactions of lipopolysaccharides of Pseudomonas aeruginosa in antipneumococcal and other antisera.

Authors:  M Heidelberger; D Horton; T H Haskell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Pseudomonas aeruginosa immunotherapy.

Authors:  J E Pennington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

3.  Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEV.

Authors:  S MacIntyre; T McVeigh; P Owen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

4.  Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.

Authors:  B J Stoll; M Pollack; L S Young; N Koles; R Gascon; G B Pier
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

5.  Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide.

Authors:  G B Pier; S E Bennett
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

6.  Cross-protection by Pseudomonas aeruginosa polysaccharides.

Authors:  G B Pier
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

7.  31P N.m.r. evidence for the presence of triphosphate residues in lipopolysaccharides from Pseudomonas aeruginosa.

Authors:  S G Wilkinson
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

8.  The absence of triphosphate or metaphosphate residues from lipopolysaccharides of the seven Fisher immunotypes of Pseudomonas aeruginosa.

Authors:  D Horton; D A Riley
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

9.  Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.

Authors:  M M Lieberman
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

10.  Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.